CAS: 2095432-55-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | SR-18292 REF: IN-DA01EB1JCAS: 2095432-55-4 | 98% | 65.00 €~568.00 € | Tue 07 Jan 25 |
 | SR-18292 REF: TM-T4353CAS: 2095432-55-4 | 99% - 99.36% | 40.00 €~917.00 € | Tue 14 Jan 25 |
 | SR 18292 REF: 3D-FS165261CAS: 2095432-55-4 | Min. 95% | 206.00 €~602.00 € | Tue 21 Jan 25 |
 | SR 18292 REF: TR-S684483CAS: 2095432-55-4 | - - - | 2,167.00 € | Tue 18 Feb 25 |
Ref: IN-DA01EB1J
| 1mg | 65.00 € | ||
| 5mg | 135.00 € | ||
| 10mg | 175.00 € | ||
| 25mg | 520.00 € | ||
| 50mg | 568.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
SR-18292
CAS:2095432-55-4
SR-18292 inhibits PGC-1α, enhances acetylation, lowers gluconeogenesis, and cuts hepatic glucose production.
Formula:
C23H30N2O2
Purity:
99% - 99.36%
Color and Shape:
Solid
Molecular weight:
366.5
Ref: TM-T4353
| 2mg | 40.00 € | ||
| 5mg | 59.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 177.00 € | ||
| 50mg | 278.00 € | ||
| 100mg | 439.00 € | ||
| 500mg | 917.00 € | ||
| 1mL*10mM (DMSO) | 71.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
SR 18292
CAS:2095432-55-4
Inhibitor of transcriptional coactivator PGC-1a; anti-diabetic agent
Formula:
C23H30N2O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
366.5 g/mol
Ref: 3D-FS165261
| 10mg | 206.00 € | ||
| 50mg | 602.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
SR 18292
Controlled ProductCAS:2095432-55-4
Formula:
C23H30N2O2
Color and Shape:
Neat
Molecular weight:
366.5
Ref: TR-S684483
| 100mg | 2,167.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
